Hörfelt Camilla, Stenquist Bo, Larkö Olle, Faergemann Jan, Wennberg Ann-Marie
Department of Dermatology, Sahlgrenska University Hopsital, Göteborg, Sweden.
Acta Derm Venereol. 2007;87(4):325-9. doi: 10.2340/00015555-0243.
Acne vulgaris does not always respond to conventional therapy. Photodynamic therapy (PDT) has been proposed as a treatment option. The aim of this study was to determine the optimal light dose for effective PDT treatment of acne and to investigate whether PDT reduces sebum excretion and the amount of Propionibacterium acnes. Fifteen patients (9 men, 6 women, age range 16-44 years, mean age 25 years) with mild to severe acne were enrolled in an open, unblinded study. Aminolaevulinic acid cream (20% in Unguentum Merck) was applied on two circular areas 3 h before PDT. The areas of investigation were irradiated with red light (635 nm) from a Waldman PDT 1200 lamp. Ten patients with facial acne were treated with a light dose of 50 J/cm(2) on the right cheek and 30 J/cm(2) on the left cheek. Five patients with acne on their back were treated either with 50 J/cm(2) or with 70 J/cm(2). Clinical follow-up was performed for at least 10 weeks. In the patients with facial acne, sebum excretion was determined before PDT and at every follow-up visit. The amount of P. acnes was measured in a skin surface biopsy using a cyano-acrylate polymer to extract the content of the sebaceous follicles. In 9 patients with facial acne the improvement of lesions was the same for the two light doses. According to the patients' own assessment, 8 improved after PDT (p=0.02). No difference was found between the two doses in patients with acne on the back. Hyperpigmentation was more common at higher doses of light, and pain was experienced more often by the patients when higher doses were used. No significant reduction in P. acnes or sebum excretion was found at any time after PDT. It is concluded that PDT could be an alternative treatment of acne lesions. The lowest possible light dose should be used for minimal side-effects. Other mechanisms of action for PDT than eradication of P. acnes and sebosuppression should be considered.
寻常痤疮并不总是对传统疗法有反应。光动力疗法(PDT)已被提议作为一种治疗选择。本研究的目的是确定有效治疗痤疮的最佳光剂量,并研究PDT是否能减少皮脂分泌和痤疮丙酸杆菌的数量。15名患有轻至重度痤疮的患者(9名男性,6名女性,年龄范围16 - 44岁,平均年龄25岁)参与了一项开放、非盲研究。在PDT前3小时,将氨基乙酰丙酸乳膏(在默克软膏中含20%)涂抹于两个圆形区域。研究区域用Waldman PDT 1200灯发出的红光(635纳米)照射。10名面部痤疮患者右脸颊接受50 J/cm²的光剂量治疗,左脸颊接受30 J/cm²的光剂量治疗。5名背部痤疮患者接受50 J/cm²或70 J/cm²的治疗。临床随访至少进行10周。对于面部痤疮患者,在PDT前及每次随访时测定皮脂分泌情况。使用氰基丙烯酸酯聚合物从皮肤表面活检中提取皮脂腺毛囊内容物来测量痤疮丙酸杆菌的数量。在9名面部痤疮患者中,两种光剂量对皮损的改善情况相同。根据患者自身评估,8名患者在PDT后病情改善(p = 0.02)。背部痤疮患者中两种剂量之间未发现差异。较高光剂量时色素沉着更常见,且患者在使用较高剂量时更常感到疼痛。PDT后任何时间均未发现痤疮丙酸杆菌或皮脂分泌有显著减少。结论是PDT可能是痤疮皮损的一种替代治疗方法。应使用尽可能低的光剂量以减少副作用。应考虑PDT除了根除痤疮丙酸杆菌和抑制皮脂分泌之外的其他作用机制。